US Patent Issued to PDS BIOTECHNOLOGY COPORATION on Feb. 17 for "Methods and compositions comprising cationic lipids for stimulating type 1 interferon genes" (American, Spanish Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,460, issued on Feb. 17, was assigned to PDS BIOTECHNOLOGY COPORATION (Princeton, N.J.).

"Methods and compositions comprising cationic lipids for stimulating type 1 interferon genes" was invented by Frank Bedu-Addo (Stamford, Conn.), Gregory Conn (Madrid), Siva K. Gandhapudi (Blue Ash, Ohio), Martin Ward (Lexington, Ky.) and Jerold Woodward (Lexington, Ky.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for modifying type I IFN signaling pathways in a subject comprising the administration a cationic lipid to the subject are provided. The cationic lipids comprise 1,2-dioleoyl-3-trimethylammonium propane (DOTAP), N-1-(2,3-dioleo...